JP2025502601A5 - - Google Patents
Info
- Publication number
- JP2025502601A5 JP2025502601A5 JP2024529602A JP2024529602A JP2025502601A5 JP 2025502601 A5 JP2025502601 A5 JP 2025502601A5 JP 2024529602 A JP2024529602 A JP 2024529602A JP 2024529602 A JP2024529602 A JP 2024529602A JP 2025502601 A5 JP2025502601 A5 JP 2025502601A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic
- parts
- weight
- polyethylene glycol
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111501847 | 2021-12-09 | ||
| CN202111501847.4 | 2021-12-09 | ||
| PCT/CN2022/134961 WO2023103835A1 (zh) | 2021-12-09 | 2022-11-29 | 一种酪氨酸激酶抑制剂眼用制剂及其制备方法和用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025502601A JP2025502601A (ja) | 2025-01-28 |
| JP2025502601A5 true JP2025502601A5 (https=) | 2025-12-04 |
Family
ID=86678145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024529602A Pending JP2025502601A (ja) | 2021-12-09 | 2022-11-29 | 眼科用チロシンキナーゼ阻害薬製剤、その調製方法及び使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250064725A1 (https=) |
| EP (1) | EP4424302A4 (https=) |
| JP (1) | JP2025502601A (https=) |
| CN (1) | CN116251186B (https=) |
| WO (1) | WO2023103835A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260025887A (ko) | 2015-06-06 | 2026-02-24 | 클라우드브레이크 테라퓨틱스, 엘엘씨 | 익상편을 치료하기 위한 조성물 및 방법 |
| AU2017274195B2 (en) | 2016-06-02 | 2022-04-07 | Ads Therapeutics Llc | Compositions and methods of using nintedanib for improving glaucoma surgery success |
| WO2025082316A1 (zh) * | 2023-10-17 | 2025-04-24 | 苏州必扬医药科技有限公司 | 一种眼用制剂及其制备方法和应用 |
| WO2025169089A1 (en) | 2024-02-05 | 2025-08-14 | Sun Pharmaceutical Industries Limited | Ophthalmic compositions of tyrosine kinase inhibitors and their uses |
| CN118986870A (zh) * | 2024-08-09 | 2024-11-22 | 山西医科大学 | 一种抑制眼部病理性血管新生的滴眼剂及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006117666A2 (en) * | 2005-04-29 | 2006-11-09 | Pfizer Inc. | Dosage forms, pharmaceutical compositions and methods for sub-tenon delivery |
| AU2010221438C1 (en) * | 2009-03-03 | 2015-01-29 | Alcon Research, Ltd. | Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| CN103110597B (zh) * | 2013-02-02 | 2018-04-13 | 浙江华海药业股份有限公司 | 盐酸厄洛替尼片及其制备方法 |
| CA2936239A1 (en) * | 2014-01-16 | 2015-07-23 | Ontogenesis, Llc | Compositions and methods for the treatment of intraocular neovascularization and/or leakage |
| TWI700085B (zh) * | 2015-06-22 | 2020-08-01 | 新源生物科技股份有限公司 | 酪胺酸激酶抑制劑之眼用調配物的用途 |
| AU2017274195B2 (en) * | 2016-06-02 | 2022-04-07 | Ads Therapeutics Llc | Compositions and methods of using nintedanib for improving glaucoma surgery success |
| EP3515444A4 (en) * | 2016-09-26 | 2020-06-03 | Reyoung (Suzhou) Biology Science & Technology Co., Ltd | COMPOSITION FOR TREATING EYE DISEASES AND METHOD FOR USE AND PRODUCTION |
| WO2020047146A1 (en) * | 2018-08-28 | 2020-03-05 | Cloudbreak Therapeutics, Llc | Emulsion formulations of multikinase inhibitors |
| CN110664757B (zh) | 2018-11-19 | 2022-08-02 | 成都瑞沐生物医药科技有限公司 | 纳米晶滴眼剂、其制备方法及其应用 |
-
2022
- 2022-10-19 CN CN202211282462.8A patent/CN116251186B/zh active Active
- 2022-11-29 EP EP22903257.8A patent/EP4424302A4/en active Pending
- 2022-11-29 JP JP2024529602A patent/JP2025502601A/ja active Pending
- 2022-11-29 WO PCT/CN2022/134961 patent/WO2023103835A1/zh not_active Ceased
- 2022-11-29 US US18/717,660 patent/US20250064725A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025502601A5 (https=) | ||
| JP7670945B2 (ja) | 老眼、散瞳、および他の眼障害の治療のための方法および組成物 | |
| EP3310356A1 (en) | Compositions for the improvement of distance vision and the treatment of refractive errors of the eye | |
| US9314427B2 (en) | Compositions and methods for the improvement of distance vision and the treatment of refractive errors of the eye | |
| JP2001510170A (ja) | 光力学的治療法において血管新生抑制性ステロイド類を使用する方法・用途 | |
| US20250064725A1 (en) | Ophthalmic preparation of tyrosine kinase inhibitor, and preparation method therefor and use thereof | |
| JP6890692B2 (ja) | 薬物送達および前眼部保護のための眼用製剤 | |
| JP2012162570A (ja) | 高眼圧症および緑内障の処置のための方法およびラタノプロスト含有組成物 | |
| US20230263907A1 (en) | Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery | |
| US20220175734A1 (en) | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality | |
| US20220257593A1 (en) | Carabachol-bromonidine formulation to enhance anti-presbyopia effects | |
| US20120277239A1 (en) | Compositions and Methods for Improving Night Vision | |
| CN108883102A (zh) | 用于治疗远视眼的组合物和方法 | |
| JP2022508715A (ja) | 緑内障および関連状態の処置のための方法および組成物 | |
| JP2025098194A (ja) | 薬剤を含む水性組成物のｐＨを安定化させるための方法 | |
| JP2024516929A5 (https=) | ||
| TW201431568A (zh) | 包含雷格拉非尼（ｒｅｇｏｒａｆｅｎｉｂ）的局部眼科醫藥組成物 | |
| US20230025836A1 (en) | Eye drop composition for preventing or treating eye disease | |
| US12576126B2 (en) | Nanoemulsion ophthalmic composition comprising cyclosporine and menthol, and preparation method thereof | |
| WO2025242194A1 (zh) | 一种拉坦前列素眼用凝胶剂及其制备方法与用途 | |
| CN103976943B (zh) | 用于治疗或预防眼部疼痛的酮咯酸氨丁三醇组合物 | |
| US20230210821A1 (en) | Using parasympathomimetic drugs alone or, in combination with one or more alpha agonists in pseudophakic patients, to create multi-focality | |
| EP4429652A1 (en) | Carbachol formulations to enhance anti-presbyopia effects | |
| JP2024515714A (ja) | 散瞳、緑内障、及び他の眼の病態を治療するための方法及び組成物 | |
| CN115463135A (zh) | 一种眼用组合物及其应用 |